DermBiont, Inc. products

A microbe is quite simply a microscopic organism. Microbes can be single-celled or comprise clusters of cells. They even include very small animals and other multicellular organisms; many are colonial and assume forms in nature that are easily visible to the naked eye. Microbes can be classified into four discrete groups.

We are focused on developing therapies that treat diseases of the skin at their root cause and fulfill the unmet needs of patients living with skin conditions. Our unique insights into the skin microbiome enable our discovery and clinical efforts. 

leverage cutting edge innovation in dermatology and proprietary technology to efficiently develop targeted small molecule therapeutics and novel microbiome-based therapeutics for dermatologic indications that address the root cause of skin diseases. Our in-house discovery platform for microbiome-based therapeutics is enabled by terabytes of DNA sequencing data derived from human skin samples across healthy individuals and patients with targeted skin diseases. Our cutting-edge proprietary computational biology platform identifies functions that are added to and lost by the microbiome as a result of a multitude of factors, enabling us to uniquely extract insights and understand the implications for skin health.